Our ingredient solutions address the full spectrum of reformulation needs from sugar reduction and protein and fibre fortification to digestive health support all within a clean label framework that meets modern consumer expectations
This makes it an ideal complement to Supresa in the Lemme GLP-1 formula, creating a comprehensive approach to metabolic support and weight management
Nurses should ask patients if they take compounded weight loss products and include them in the medication reconciliation
Clinical data show that discontinuing GLP-1 therapy has been associated with weight regain in many participants
Clinical trial data show that injectable options slightly outperform oral options for weight loss, but real-world results vary by adherence and tolerability
At 48 weeks, the least-squares mean percentage change in body weight was -8.7% in the 1 mg group, -17.1% in the combined 4 mg group, -22.8% in the combined 8 mg group, and -24.2% in the 12 mg group, compared with -2.1% in the placebo group
